BridgeBio (BBIO) Q1 2026 Earnings Report Shows Strong Revenue Growth
BridgeBio reported strong sequential and year-over-year revenue growth in its first-quarter earnings for 2026, driven by increased sales of Atruvio. Total revenues reached $194.5 million with a significant increase attributed to higher net product revenue.
Tickers: $BBIO
Topics: Atruvio cash reserves operating expenses revenue growth